Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2007; 49:1589-1599, doi:10.1016/j.jacc.2006.12.045 (Published online 30 March 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, D. T.
Right arrow Articles by Kwiatkowski, D. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Miller, D. T.
Right arrow Articles by Kwiatkowski, D. J.

Atherosclerosis

The Path From Genomics to Therapeutics

David T. Miller, MD, PhD*,§,1, Paul M. Ridker, MD, MPH, FACC{dagger},{ddagger},§,2, Peter Libby, MD, FACC{ddagger},§,* and David J. Kwiatkowski, MD, PhD*,§

* Division of Hematology, Brigham and Women’s Hospital, Boston, Massachusetts
{dagger} Division of Preventive Medicine and Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital, Boston, Massachusetts
{ddagger} Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
§ Donald W. Reynolds Cardiovascular Clinical Research Center on Atherosclerosis at Brigham and Women’s Hospital and the Harvard Medical School, Boston, Massachusetts.


Figure 1
View larger version (91K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Genetic Information: SNPs and Haplotypes

The C-reactive protein (CRP) gene structure, single nucleotide polymorphisms (SNPs), and haplotypes; (A) CRP consists of 2 exons comprising coding regions (darkest shading) and noncoding regions (medium shading) and has 7 common SNPs indicated by rs numbers and relative position. (B) Sequencing traces of a G/C SNP in exon 2 shows the G/G version (black peak, top) and G/C version (black/blue peak, bottom). (C) Different combinations of alleles at each of the 7 SNP positions create 6 common haplotypes for this set of CRP SNPs. Illustration by Rob Flewell.

 

Figure 2
View larger version (61K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Levels of Genomic and Proteomic Information

Capturing all genomic and proteomic information requires a combined approach that targets DNA, RNA, and proteins. The single nucleotide polymorphisms (SNPs) may influence gene expression (e.g., by altering a transcriptional activator binding site in the promoter), or gene function (e.g., by causing an amino acid change). Transcriptional activators (TA), repressors (TR), and mRNA turnover influence mRNA levels independent of SNP genotypes; these mechanisms would only be detectable by expression profiling. Although mRNA levels may vary within and among cells, regulation of protein trafficking, turnover, or structure could affect a protein level or function independently from genotype or mRNA regulation. Illustration by Rob Flewell.

 

Figure 3
View larger version (55K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Coordination of Information for Clinical Decision-Making

Informed clinical decision-making based on genomic information will require synthesis of diverse pieces of data. The relative significance of genomic, proteomic, and metabolomic markers could vary among patients. Such information must be considered in the context of personal medical history, family history, other clinical and laboratory data, and environmental variables. ECG = electrocardiography. Illustration by Rob Flewell.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement